129(top 2%)
PR articles
58.5K(top 0.1%)
PR citations
59(top 1%)
PR h-index
60(top 1%)
h-index
133
documents
71.2K
doc citations
8.5K
citing journals
100
times ranked

Publications

129 peer-reviewed articles • 64,206 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Ultra-Early Hematoma Expansion Is Associated With Ongoing Hematoma Growth and Poor Functional Outcome
Stroke, 2025, 56, 838-847
5.912Citations (PDF)
2Tenecteplase versus alteplase for stroke thrombolysis evaluation (TASTE): A multicentre, prospective, randomized, open-label, blinded-endpoint, controlled phase III non-inferiority trial protocol
International Journal of Stroke, 2023, 18, 751-756
6.48Citations (PDF)
3Temporal and age-specific trends in incidence and 1-year case-fatality of hospitalized ischaemic stroke in Victoria, Australia
Journal of Stroke and Cerebrovascular Diseases, 2023, 32, 107331
1.62Citations (PDF)
4Management of Poststroke Hyperglycemia: Results of the TEXAIS Randomized Clinical Trial
Stroke, 2023, 54, 2962-2971
5.934Citations (PDF)
5Does variability in automated perfusion software outputs for acute ischemic stroke matter? Reanalysis of EXTEND perfusion imaging
CNS Neuroscience and Therapeutics, 2022, 28, 139-144
5.09Citations (PDF)
6Does tranexamic acid affect intraventricular hemorrhage growth in acute ICH? An analysis of the STOP-AUST trial
European Stroke Journal, 2022, 7, 15-19
3.88Citations (PDF)
7Inflammation parameters predict fatal outcome in male COVID-19 patients in a low case-fatality area – a population-based registry study
Infectious Diseases, 2022, 54, 558-571
1.75Citations (PDF)
8The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study
Archives of Public Health, 2022, 80,
2.632Citations (PDF)
9Occipital intracerebral hemorrhage—clinical characteristics, outcome, and post‐ICH epilepsy
Acta Neurologica Scandinavica, 2021, 143, 71-77
2.92Citations (PDF)
10Male predominance in disease severity and mortality in a low Covid-19 epidemic and low case-fatality area – a population-based registry study
Infectious Diseases, 2021, 53, 789-799
1.732Citations (PDF)
11Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050
Lancet, The, 2021, 398, 1317-1343
62.1133Citations (PDF)
12Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial
Lancet Neurology, The, 2020, 19, 980-987
17.9138Citations (PDF)
13Three-month modified Rankin Scale as a determinant of 5-year cumulative costs after ischemic stroke
Neurology, 2020, 94,
1.027Citations (PDF)
14Improving economic evaluations in stroke: A report from the ESO Health Economics Working Group
European Stroke Journal, 2020, 5, 184-192
3.820Citations (PDF)
15Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3
Lancet, The, 2020, 396, 693-724
62.1138Citations (PDF)
16Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017
Injury Prevention, 2020, 26, i12-i26
1.693Citations (PDF)
17Outcome After Clipping and Coiling for Aneurysmal Subarachnoid Hemorrhage in Clinical Practice in Europe, USA, and Australia
Neurosurgery, 2019, 84, 1019-1027
2.029Citations (PDF)
18Hospital case-volume is associated with case-fatality after aneurysmal subarachnoid hemorrhage
International Journal of Stroke, 2019, 14, 282-289
6.421Citations (PDF)
19Mapping 123 million neonatal, infant and child deaths between 2000 and 2017
Nature, 2019, 574, 353-358
37.9233Citations (PDF)
20Trends and Predictors of Oral Anticoagulant Use in People with Alzheimer’s Disease and the General Population in Australia
Journal of Alzheimer's Disease, 2019, 70, 733-745
2.610Citations (PDF)
21Prevalence, Safety, and Effectiveness of Oral Anticoagulant Use in People with and without Dementia or Cognitive Impairment: A Systematic Review and Meta-Analysis
Journal of Alzheimer's Disease, 2019, 71, 1375-1378
2.63Citations (PDF)
22Changes in acute hospital costs after employing clinical facilitators to improve stroke care in Victoria, Australia
BMC Health Services Research, 2019, 19,
2.58Citations (PDF)
23Antipsychotic Use Among 1144 Patients After Aneurysmal Subarachnoid Hemorrhage
Stroke, 2019, 50, 1711-1718
5.917Citations (PDF)
24Effect of baseline hypocalcaemia on volume of intracerebral haemorrhage in patients presenting within 72 hours from symptom onset
Journal of the Neurological Sciences, 2019, 403, 24-29
2.18Citations (PDF)
25Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data
Lancet, The, 2019, 394, 139-147
62.1481Citations (PDF)
26Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
New England Journal of Medicine, 2019, 380, 1795-1803
34.5955Citations (PDF)
27Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995–2050
Lancet, The, 2019, 393, 2233-2260
62.1386Citations (PDF)
28Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Lancet Neurology, The, 2019, 18, 439-458
17.92,635Citations (PDF)
29Life expectancy and disease burden in the Nordic countries: results from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017
Lancet Public Health, The, 2019, 4, e658-e669
18.786Citations (PDF)
30Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Lancet Neurology, The, 2019, 18, 88-106
17.92,111Citations (PDF)
31Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Lancet Neurology, The, 2019, 18, 56-87
17.91,726Citations (PDF)
32Development of a Non-invasive Device for Swallow Screening in Patients at Risk of Oropharyngeal Dysphagia: Results from a Prospective Exploratory Study
Dysphagia, 2019, 34, 698-707
2.648Citations (PDF)
33Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995–2015
Lancet, The, 2018, 391, 1799-1829
62.1155Citations (PDF)
34Trends in future health financing and coverage: future health spending and universal health coverage in 188 countries, 2016–40
Lancet, The, 2018, 391, 1783-1798
62.1215Citations (PDF)
35The Burden of Cardiovascular Diseases Among US States, 1990-2016
JAMA Cardiology, 2018, 3, 375
11.1344Citations (PDF)
36Diabetes and intracerebral hemorrhage: baseline characteristics and mortality
European Journal of Neurology, 2018, 25, 825-832
3.527Citations (PDF)
37Beta-blocker therapy is not associated with mortality after intracerebral hemorrhage
Acta Neurologica Scandinavica, 2018, 137, 105-108
2.96Citations (PDF)
38Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Lancet, The, 2018, 392, 1789-1858
62.111,792Citations (PDF)
39Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016
New England Journal of Medicine, 2018, 379, 2429-2437
34.51,382Citations (PDF)
40Neuroimaging and clinical outcomes of oral anticoagulant–associated intracerebral hemorrhage
Annals of Neurology, 2018, 84, 694-704
6.662Citations (PDF)
41Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016
Lancet, The, 2018, 391, 2236-2271
62.1863Citations (PDF)
42Helsinki Stroke Model Is Transferrable With “Real-World” Resources and Reduced Stroke Thrombolysis Delay to 34 min in Christchurch
Frontiers in Neurology, 2018, 9,
2.329Citations (PDF)
43Prevalence, Safety, and Effectiveness of Oral Anticoagulant Use in People with and without Dementia or Cognitive Impairment: A Systematic Review and Meta-Analysis
Journal of Alzheimer's Disease, 2018, 65, 489-517
2.617Citations (PDF)
44Treatment of intracerebral haemorrhage with tranexamic acid – A review of current evidence and ongoing trials
European Stroke Journal, 2017, 2, 13-22
3.821Citations (PDF)
45Simultaneous Multiple Intracerebral Hemorrhages (SMICH)
Stroke, 2017, 48, 581-586
5.930Citations (PDF)
46Future and potential spending on health 2015–40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries
Lancet, The, 2017, 389, 2005-2030
62.1187Citations (PDF)
47Evolution and patterns of global health financing 1995–2014: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries
Lancet, The, 2017, 389, 1981-2004
62.1247Citations (PDF)
48Endovascular therapy for ischemic stroke
Neurology, 2017, 88, 2123-2127
1.0172Citations (PDF)
49Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015
Journal of the American College of Cardiology, 2017, 70, 1-25
2.33,390Citations (PDF)
50Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015
Lancet, The, 2017, 390, 231-266
62.1656Citations (PDF)
51Stroke doctors: Who are we? A World Stroke Organization survey
International Journal of Stroke, 2017, 12, 858-868
6.422Citations (PDF)
52Outcome of intracerebral hemorrhage associated with different oral anticoagulants
Neurology, 2017, 88, 1693-1700
1.0141Citations (PDF)
53Natural History of Perihematomal Edema and Impact on Outcome After Intracerebral Hemorrhage
Stroke, 2017, 48, 873-879
5.9126Citations (PDF)
54Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016
Lancet, The, 2017, 390, 1084-1150
62.1679Citations (PDF)
55Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Lancet, The, 2017, 390, 1260-1344
62.11,857Citations (PDF)
56Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
Lancet, The, 2017, 390, 1151-1210
62.14,292Citations (PDF)
57Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Lancet, The, 2017, 390, 1211-1259
62.17,076Citations (PDF)
58Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
Lancet Neurology, The, 2017, 16, 877-897
17.92,041Citations (PDF)
59Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016
Lancet, The, 2017, 390, 1423-1459
62.1320Citations (PDF)
60Persistent Hyperglycemia Is Associated With Increased Mortality After Intracerebral Hemorrhage
Journal of the American Heart Association, 2017, 6,
4.046Citations (PDF)
61Comparison of all 19 published prognostic scores for intracerebral hemorrhage
Journal of the Neurological Sciences, 2017, 379, 103-108
2.154Citations (PDF)
62Endovascular Thrombectomy for Ischemic Stroke Increases Disability-Free Survival, Quality of Life, and Life Expectancy and Reduces Cost
Frontiers in Neurology, 2017, 8,
2.362Citations (PDF)
63Treatment of intracerebellar haemorrhage: Poor outcome and high long-term mortality
2017, 8, 272
12Citations (PDF)
64Reply
Annals of Neurology, 2016, 79, 332-333
6.61Citations (PDF)
65Validation of a decision support model for investigation and improvement in stroke thrombolysis
European Journal of Operational Research, 2016, 253, 154-169
5.78Citations (PDF)
66Airplane stroke syndrome
Journal of Clinical Neuroscience, 2016, 29, 77-80
1.68Citations (PDF)
67Reliability of intracerebral hemorrhage classification systems: A systematic review
International Journal of Stroke, 2016, 11, 626-636
6.455Citations (PDF)
68Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
Lancet, The, 2016, 388, 1775-1812
62.1988Citations (PDF)
69Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
Lancet, The, 2016, 388, 1603-1658
62.11,891Citations (PDF)
70Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
Lancet, The, 2016, 388, 1459-1544
62.15,762Citations (PDF)
71Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
Lancet, The, 2016, 388, 1545-1602
62.16,295Citations (PDF)
72Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
Lancet, The, 2016, 388, 1659-1724
62.14,791Citations (PDF)
73Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
Lancet, The, 2016, 388, 1725-1774
62.1672Citations (PDF)
74Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015
Lancet, The, 2016, 388, 1813-1850
62.1501Citations (PDF)
75Software output from semi-automated planimetry can underestimate intracerebral haemorrhage and peri-haematomal oedema volumes by up to 41 %
Neuroradiology, 2016, 58, 867-876
2.128Citations (PDF)
76Stroke Thrombolysis in a Centralized and a Decentralized System (Helsinki and Telemedical Project for Integrative Stroke Care Network)
Stroke, 2016, 47, 2999-3004
5.942Citations (PDF)
77Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015
Lancet HIV,the, 2016, 3, e361-e387
7.9502Citations (PDF)
78Impact of pre-stroke sulphonylurea and metformin use on mortality of intracerebral haemorrhage
European Stroke Journal, 2016, 1, 302-309
3.812Citations (PDF)
79National stroke registries for monitoring and improving the quality of hospital care: A systematic review
International Journal of Stroke, 2016, 11, 28-40
6.4137Citations (PDF)
80Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage
Annals of Neurology, 2015, 78, 54-62
6.695Citations (PDF)
81Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
Lancet, The, 2015, 386, 743-800
62.15,638Citations (PDF)
82Incidence, risk factors, etiology, severity and short‐term outcome of non‐traumatic intracerebral hemorrhage in young adults
European Journal of Neurology, 2015, 22, 123-132
3.570Citations (PDF)
83Extent of Secondary Intraventricular Hemorrhage is an Independent Predictor of Outcomes in Intracerebral Hemorrhage: Data from the Helsinki ICH Study
International Journal of Stroke, 2015, 10, 576-581
6.437Citations (PDF)
84Comparing ischaemic stroke in six European countries. The EuroHOPEregister study
European Journal of Neurology, 2015, 22, 284
3.542Citations (PDF)
85Twenty-Year History of the Evolution of Stroke Thrombolysis With Intravenous Alteplase to Reduce Long-Term Disability
Stroke, 2015, 46, 2341-2346
5.963Citations (PDF)
86Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition
Lancet, The, 2015, 386, 2145-2191
62.11,751Citations (PDF)
87Undetermined stroke with an embolic pattern—a common phenotype with high early recurrence risk
Annals of Medicine, 2015, 47, 406-413
3.834Citations (PDF)
88Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
Lancet, The, 2015, 386, 2287-2323
62.12,474Citations (PDF)
89Imaging Selection in Ischemic Stroke: Feasibility of Automated CT-Perfusion Analysis
International Journal of Stroke, 2015, 10, 51-54
6.4113Citations (PDF)
90Mild Hypothermia After Intravenous Thrombolysis in Patients With Acute Stroke
Stroke, 2014, 45, 486-491
5.9120Citations (PDF)
91Evolution of Intracerebral Hemorrhage after Intravenous Tpa: Reversal of Harmful Effects with Mast Cell Stabilization
Journal of Cerebral Blood Flow and Metabolism, 2014, 34, 176-181
4.713Citations (PDF)
92Multicenter Accuracy and Interobserver Agreement of Spot Sign Identification in Acute Intracerebral Hemorrhage
Stroke, 2014, 45, 107-112
5.927Citations (PDF)
93The Spot Sign and Tranexamic Acid on Preventing ICH Growth – AUStralasia Trial (STOP-AUST): Protocol of a Phase II Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial
International Journal of Stroke, 2014, 9, 519-524
6.465Citations (PDF)
94Lost potential of kidney and liver donors amongst deceased intracerebral hemorrhage patients
European Journal of Neurology, 2014, 21, 153-159
3.59Citations (PDF)
95Do-Not-Resuscitate (DNR) Orders in Patients with Intracerebral Hemorrhage
International Journal of Stroke, 2014, 9, 53-58
6.454Citations (PDF)
96In-Hospital Cardiac Complications after Intracerebral Hemorrhage
International Journal of Stroke, 2014, 9, 741-746
6.450Citations (PDF)
97Symptomatic Intracranial Hemorrhage After Stroke Thrombolysis
Stroke, 2014, 45, 752-758
5.974Citations (PDF)
98Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
Lancet, The, 2014, 384, 957-979
62.1675Citations (PDF)
99Higher baseline international normalized ratio value correlates with higher mortality in intracerebral hemorrhage during warfarin use
European Journal of Neurology, 2014, 21, 616-622
3.533Citations (PDF)
100The CAVE Score for Predicting Late Seizures After Intracerebral Hemorrhage
Stroke, 2014, 45, 1971-1976
5.9220Citations (PDF)
101Stroke Thrombolysis
Stroke, 2014, 45, 1053-1058
5.9331Citations (PDF)
102Outcome of ischemic stroke patients with serious post-thrombolysis neurological deficits
Acta Neurologica Scandinavica, 2013, 127, 221-226
2.95Citations (PDF)
103Cerebral Edema in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis
International Journal of Stroke, 2013, 8, 529-534
6.469Citations (PDF)
104Intravenous Thrombolysis for Acute Ischemic Stroke Patients Presenting with Mild Symptoms
International Journal of Stroke, 2013, 8, 293-299
6.433Citations (PDF)
105Thrombolysis in Stroke Despite Contraindications or Warnings?
Stroke, 2013, 44, 727-733
5.9116Citations (PDF)
106Elevated urea level is associated with poor clinical outcome and increased mortality post intravenous tissue plasminogen activator in stroke patients
Journal of the Neurological Sciences, 2013, 332, 110-115
2.119Citations (PDF)
107Warfarin-associated intracerebral hemorrhage: Volume, anticoagulation intensity and location
Journal of the Neurological Sciences, 2013, 332, 75-79
2.126Citations (PDF)
108Body Temperature, Blood Infection Parameters, and Outcome of Thrombolysis-Treated Ischemic Stroke Patients
International Journal of Stroke, 2013, 8, 632-638
6.436Citations (PDF)
109Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months
Neurology, 2013, 81, 1071-1076
1.0261Citations (PDF)
110Validation of the DRAGON Score in 12 Stroke Centers in Anterior and Posterior Circulation
Stroke, 2013, 44, 2718-2721
5.947Citations (PDF)
111Novel Thrombolytic Drugs
CNS Drugs, 2012, 22, 619-629
6.314Citations (PDF)
112Reducing in-hospital delay to 20 minutes in stroke thrombolysis
Neurology, 2012, 79, 306-313
1.0533Citations (PDF)
113Pre‐ and in‐hospital intersection of stroke care
Annals of the New York Academy of Sciences, 2012, 1268, 145-151
4.033Citations (PDF)
114Predicting outcome of IV thrombolysis–treated ischemic stroke patients
Neurology, 2012, 78, 427-432
1.0253Citations (PDF)
115In reply
Annals of Emergency Medicine, 2012, 60, 246-247
1.50Citations (PDF)
116SMASH-U
Stroke, 2012, 43, 2592-2597
5.9333Citations (PDF)
117Symptomatic intracranial hemorrhage after stroke thrombolysis: The SEDAN Score
Annals of Neurology, 2012, 71, 634-641
6.6279Citations (PDF)
118Stroke Mimics and Intravenous Thrombolysis
Annals of Emergency Medicine, 2012, 59, 27-32
1.567Citations (PDF)
119Does Time of Day Or Physician Experience Affect Outcome of Acute Ischemic Stroke Patients Treated with Thrombolysis? a Study from Finland
International Journal of Stroke, 2012, 7, 511-516
6.443Citations (PDF)
120Hemiplegia and thrombolysis
European Journal of Neurology, 2012, 19, 1235-1238
3.57Citations (PDF)
121Trends in treatment and outcome of stroke patients in Finland from 1999 to 2007. PERFECT Stroke, a nationwide register study
Annals of Medicine, 2011, 43, S22-S30
3.842Citations (PDF)
122Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis
Neurology, 2011, 77, 341-348
1.0194Citations (PDF)
123Outcome by Stroke Etiology in Patients Receiving Thrombolytic Treatment
Stroke, 2011, 42, 102-106
5.9100Citations (PDF)
124Direct Costs of Patients With Stroke Can Be Continuously Monitored on a National Level
Stroke, 2011, 42, 2007-2012
5.937Citations (PDF)
125Response to Letter by Longstreth and Tirschwell
Stroke, 2010, 41,
5.90Citations (PDF)
126Effectiveness of Primary and Comprehensive Stroke Centers
Stroke, 2010, 41, 1102-1107
5.9136Citations (PDF)
127Stroke Monitoring on a National Level
Stroke, 2010, 41, 2239-2246
5.963Citations (PDF)
128Off-Label Thrombolysis Is Not Associated With Poor Outcome in Patients With Stroke
Stroke, 2010, 41, 1450-1458
5.9203Citations (PDF)
129Epidemiology of hereditary neuropathy with liability to pressure palsies (HNPP) in south western Finland
Neuromuscular Disorders, 1997, 7, 529-532
0.796Citations (PDF)